Dashboard
Manage Tickers

TCRRTCR2 THERAPEUTICS INC.

Nasdaq tcr2.com


$ 1.54 $ -0.09 (-5.73 %)    

Wednesday, 31-May-2023 15:57:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 1.48
$ 1.61
$ 1.48 x 2,000
$ 1.56 x 500
$ 1.52 - $ 1.63
$ 0.82 - $ 3.88
3,913,314
na
58.05M
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-11-2023 03-31-2023 10-Q
2 03-23-2023 12-31-2022 10-K
3 11-08-2022 09-30-2022 10-Q
4 08-08-2022 06-30-2022 10-Q
5 05-12-2022 03-31-2022 10-Q
6 03-22-2022 12-31-2021 10-K
7 11-10-2021 09-30-2021 10-Q
8 08-05-2021 06-30-2021 10-Q
9 05-13-2021 03-31-2021 10-Q
10 03-16-2021 12-31-2020 10-K
11 11-12-2020 09-30-2020 10-Q
12 08-12-2020 06-30-2020 10-Q
13 05-14-2020 03-31-2020 10-Q
14 03-30-2020 12-31-2019 10-K
15 11-12-2019 09-30-2019 10-Q
16 08-09-2019 06-30-2019 10-Q
17 05-13-2019 03-31-2019 10-Q
18 03-29-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Esperion Therapeutics And 2 Other Stocks U...
05/11/2023 13:25:42

The Dow Jones closed slightly lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or conce...

recap-tcr2-therapeutics-q1-earnings
Recap: TCR2 Therapeutics Q1 Earnings
05/11/2023 12:11:31

tcr2-therapeutics-q1-eps-103-down-from-076-yoy
TCR2 Therapeutics Q1 EPS $(1.03) Down From...
05/11/2023 10:46:02

TCR2 Therapeutics (NASDAQ:TCRR) reported quarterly losses of $(1.03) per share. This is a 35.53 percent decrease over losses of...

ribbon-communications-and-2-other-stocks-under-3-insiders-are-aggressively-buying
Ribbon Communications And 2 Other Stocks U...
05/08/2023 11:41:10

The Dow Jones jumped more than 500 points on Friday. When insiders purchase or sell shares, it indicates their confidence or co...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
03/24/2023 15:00:25

mizuho-downgrades-tcr2-therapeutics-to-neutral-lowers-price-target-to-172
Mizuho Downgrades TCR2 Therapeutics to Neu...
03/24/2023 10:35:15

Mizuho analyst Mara Goldstein downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Neutral and lowers the price target fro...

ef-hutton-reiterates-hold-on-tcr2-therapeutics-maintains-2-price-target
EF Hutton Reiterates Hold on TCR2 Therapeu...
03/23/2023 13:25:23

EF Hutton analyst Tony Butler reiterates TCR2 Therapeutics (NASDAQ:TCRR) with a Hold and maintains $2 price target.

tcr2-therapeutics-q4-eps-156-vs-072-prior-year
TCR2 Therapeutics Q4 EPS $(1.56) Vs. $(0.7...
03/23/2023 10:39:42

TCR2 Therapeutics (NASDAQ:TCRR) reported quarterly losses of $(1.56) per share. This is a 116.67 percent decrease over losses o...

what-to-know-about-jefferiess-downgrade-of-tcr2-therapeutics
What To Know About Jefferies's Downgrade o...
03/09/2023 17:02:29

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
03/09/2023 15:00:39

4-analysts-have-this-to-say-about-tcr2-therapeutics
4 Analysts Have This to Say About TCR2 The...
03/09/2023 13:01:15

jefferies-downgrades-tcr2-therapeutics-to-underperform-lowers-price-target-to-3
Jefferies Downgrades TCR2 Therapeutics to ...
03/09/2023 10:57:01

Jefferies analyst Kelly Shi downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Underperform and lowers the price target ...

benzingas-top-ratings-upgrades-downgrades-for-march-8-2023
Benzinga's Top Ratings Upgrades, Downgrade...
03/08/2023 15:00:33

truist-securities-downgrades-tcr2-therapeutics-to-hold-lowers-price-target-to-3
Truist Securities Downgrades TCR2 Therapeu...
03/08/2023 14:43:00

Truist Securities analyst Asthika Goonewardene downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Hold and lowers the pr...

health-care-etfs-have-lost-in-the-last-month---these-top-pharma-stocks-are-the-reason
Health Care ETFs Have Lost In The Last Mon...
03/08/2023 00:34:06

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
03/07/2023 15:00:40

hc-wainwright--co-downgrades-tcr2-therapeutics-to-neutral
HC Wainwright & Co. Downgrades TCR2 Therap...
03/07/2023 11:13:17

HC Wainwright & Co. analyst Robert Burns downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Neutral.

why-is-tcr2-therapeutics-stock-trading-higher-today
Why Is TCR2 Therapeutics Stock Trading Hig...
03/06/2023 19:01:10

TCR² Therapeutics (NASDAQ: TCRR) shares are trading higher on Monday after the company and Adaptimmune Therapeutics (NASDAQ: AD...

why-aclaris-therapeutics-shares-are-trading-lower-by-around-55-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Aclaris Therapeutics Shares Are Tradin...
03/06/2023 18:25:46

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placem...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
03/06/2023 17:31:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION